Ben Taylor

Ben Taylor

Director of Finance/CFO at RECURSION PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 31/05/2026

48 year
Health Technology
Finance
Technology Services

Profile

Ben R.
Taylor
is Chief Financial Officer & President-UK Region at Recursion Pharmaceuticals, Inc. since 2024.
Formerly, Chief Financial Officer & Executive Director at Exscientia AI Ltd. from 2020 to 2024.
Chief Financial & Strategy Officer, Director at Exscientia Ltd. Head-Emerging Pharm at Goldman Sachs & Co. LLC from 2012 to 2016.
Head-Commercial Pharm at Barclays Capital, Inc. from 2016 to 2017.
President & Chief Financial Officer at Tyme Technologies, Inc. from 2017 to 2020.
Chief Financial Officer at Aetion, Inc. in 2020.
Education includes undergraduate degree from Brown University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/06/2026 11,01,876 ( 0.21% ) 4 M $ 31/05/2026

Ben Taylor active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Director of Finance/CFO 20/11/2024

Former positions of Ben Taylor

CompaniesPositionEnd
Director of Finance/CFO 01/11/2024
Director of Finance/CFO 01/11/2020
TYME TECHNOLOGIES, INC. Director of Finance/CFO 01/08/2020
Corporate Officer/Principal 01/01/2017
Corporate Officer/Principal 01/02/2016
See the detail of Ben Taylor's experience

Training of Ben Taylor

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Finance

Finance

Technology Services

Health Technology

Technology Services

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!